Company research

Explore company profiles, quarterly results, announcements and ownership disclosures.

Loading the company view…

Clinitech Laboratory Ltd (CTLLAB) — Stock Analysis

Clinitech Laboratory Ltd (NSE: CTLLAB), ISIN INE0QMR01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

CTLLAB last traded at ₹35.10, with a 52-week range of ₹28.55 to ₹57.00 (as of 1 Sep 2026).

Shareholding as of Sep 2025: promoters 62.42%, FIIs 0.32%, DIIs 0.00%, mutual funds 0.00%.

EquiSense Score (ECS): 49/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.